EXEL Competitors & Alternatives
Compare Exelixis Inc with similar stocks in the same industry
Biotechnology
EXEL
Main Stock$54.08
Tradestie Score
52
Market Cap
$11.09B
P/E Ratio
16.9
Revenue Growth
0.1%
Analyst Upside
-2.0%
Top Competitors
237 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$61.31
|
$15.70B | 32.6 | 42 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$13.16
|
$15.22B | - | 55 | Compare |
|
NBIX
Neurocrine Biosciences Inc
|
$152.57
|
$13.59B | 22.7 | 67 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$253.29
|
$12.36B | 19.7 | 51 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$36.30
|
$10.76B | - | 48 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$145.13
|
$10.74B | - | 40 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$66.70
|
$10.53B | 188.0 | 42 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$59.74
|
$10.49B | - | 40 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$81.50
|
$10.22B | - | 52 | Compare |
|
MDGL
Madrigal Pharmaceuticals, Inc. Common Stock
|
$516.74
|
$10.01B | - | 51 | Compare |
More EXEL Analysis
Data updated: Aug 24, 2026 | Industry: Biotechnology (SIC 2836)
237 stocks in this industry